Burkina Faso vs Sri Lanka: Incidence of tuberculosis
Incidence of tuberculosis over time
- Burkina Faso
- Sri Lanka
How they compare
Sri Lanka currently reports 59 per 100,000 people against 57 per 100,000 people in Burkina Faso, a difference of 2 per 100,000 people.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Sri Lanka ahead.
Burkina Faso ranks 86th and Sri Lanka ranks 84th of 208 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Burkina Faso | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.7 per 100,000 people | 117 per 100,000 people | 32.3 per 100,000 people | Sri Lanka |
| 2010s | 69.2 per 100,000 people | 71.9 per 100,000 people | 2.7 per 100,000 people | Sri Lanka |
| 2020s | 59.4 per 100,000 people | 56.4 per 100,000 people | 3 per 100,000 people | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Burkina Faso or Sri Lanka?
- Sri Lanka, at 59 per 100,000 people against 57 per 100,000 people in Burkina Faso as of 2024.
- What is the difference in incidence of tuberculosis between Burkina Faso and Sri Lanka?
- 2 per 100,000 people, with Sri Lanka ahead.
- How many years of comparable data are there for Burkina Faso and Sri Lanka?
- 25 years are reported by both, from 2000 to 2024.
- How do Burkina Faso and Sri Lanka rank globally for incidence of tuberculosis?
- Burkina Faso ranks 86th and Sri Lanka ranks 84th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.